 |
|
http://www.endotoxin.com
Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and Gram-negative septicemia (endotoxemia), as well as an ...
adenosine,
a1ar,
inflammation,
anti-inflammatory,
endotoxin,
endotoxemia,
septicemia,
sepsis,
asthma,
ischemia,
reperfusion,
ischemia-reperfusion,
p2x,
purinoceptor,
gram-negative,
fibrosis,
sclerosis,
myocardial,
infarction,
purine,
copd,
autoimmune,
|
|
|
|
|
